Market Research Logo

Smoking Cessation Pipeline Highlights – 2017 Update

Smoking Cessation Pipeline Highlights – 2017 Update

The latest report from Fore Pharma, Smoking Cessation Pipeline Highlights – 2017 Update, provides most up-to-date information on key pipeline products in the global Smoking Cessation market. It covers emerging therapies for Smoking Cessation in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Smoking Cessation pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Smoking Cessation pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Smoking Cessation pipeline products by the company.

Short-term Launch Highlights:
Find out which Smoking Cessation pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:

  • Smoking Cessation phase 3 clinical trial pipeline products
  • Smoking Cessation phase 2 clinical trial pipeline products
  • Smoking Cessation phase 1 clinical trial pipeline products
  • Smoking Cessation preclinical research pipeline products
  • Smoking Cessation discovery stage pipeline products
  • Smoking Cessation pipeline products short-term launch highlights


1. Smoking Cessation Pipeline by Stages
2. Smoking Cessation Pipeline by Drug Class
3. Smoking Cessation Pipeline by Company
4. Smoking Cessation Phase 3 Clinical Trial Insights
5. Smoking Cessation Phase 2 Clinical Trial Insights
6. Smoking Cessation Phase 1 Clinical Trial Insights
7. Smoking Cessation Preclinical Research Insights
8. Smoking Cessation Discovery Stage Insights
9. Appendix
10. Research Methodology
LIST OF TABLES
Table 1: Smoking Cessation Phase 3 Clinical Trials, 2017
Table 2: Smoking Cessation Phase 2 Clinical Trials, 2017
Table 3: Smoking Cessation Phase 1 Clinical Trials, 2017
Table 4: Smoking Cessation Preclinical Research, 2017
Table 5: Smoking Cessation Discovery Stage, 2017
LIST OF FIGURES
Figure 1: Smoking Cessation Pipeline Molecules by Clinical Trials Stage, 2017
Figure 2: Smoking Cessation Pipeline Molecules by Drug Class, 2017
Figure 3: Smoking Cessation Pipeline Molecules by Company, 2017
Figure 4: Smoking Cessation Phase 3 Clinical Trial Highlights, 2017
Figure 5: Smoking Cessation Phase 2 Clinical Trial Highlights, 2017
Figure 6: Smoking Cessation Phase 1 Clinical Trial Highlights, 2017
Figure 7: Smoking Cessation Preclinical Research Highlights, 2017
Figure 8: Smoking Cessation Discovery Stage Highlights, 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report